Results 251 to 260 of about 37,267 (288)

Isolated AL Amyloidosis of the Colon: A Rare Presentation. [PDF]

ACG Case Rep J
Garcia A, Qureshi M, Dhawa I, Rafferty W, Budak-Alpdogan T, Giordano S.   +5 more
europepmc   +1 more source

The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type

Annals of Clinical and Translational Neurology, Volume 12, Issue 7, Page 1408-1417, July 2025.
ABSTRACT Objective Determine the association between diabetes and metabolic syndrome (MetS) burden (number of MetS criteria fulfilled) and pain, neuropathy severity, and fiber type involvement in individuals with established polyneuropathy. Methods The Peripheral Neuropathy Research Registry was queried for individuals with type 1 and type 2 diabetes ...
Long Davalos, Brian C. Callaghan, Lavanya Muthukumar, Simone Thomas, Evan L. Reynolds, A. Gordon Smith, J. Robinson Singleton, Ahmet Höke, Senda Ajroud‐Driss, Mazen M. Dimachkie, Stefanie Geisler, David M. Simpson, PNRR Study Group, Amro M. Stino   +13 more
wiley   +1 more source

Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management. [PDF]

J Clin Med
Shafqat A, Elmaleh H, Mushtaq A, Firdous Z, Ashruf O, Mukhopadhyay D, Ahmad M, Ahmad M, Raza S, Anwer F.   +9 more
europepmc   +1 more source

A novel approach to resilience and its links with education and Alzheimer's disease genetics

Alzheimer's &Dementia, Volume 21, Issue 7, July 2025.
Abstract INTRODUCTION Cognitive resilience refers to maintaining cognitive function despite Alzheimer's disease (AD) pathophysiology. METHODS We analyzed amyloid‐positive individuals across clinical stages of AD in two cohorts: the Amsterdam Dementia Cohort (ADC, N = 1036) and Alzheimer's Disease Neuroimaging Initiative (ADNI, N = 685).
Maria Carrigan, Diana I. Bocancea, Jacob Vogel, Anna C. van Loenhoud, Niccoló Tesi, Frederik Barkhof, Paul J. Lucassen, Wiesje M. van der Flier, Harm J. Krugers, Sven J. Van der Lee, Rik Ossenkoppele   +10 more
wiley   +1 more source

Healthcare resource utilisation and costs associated with AL amyloidosis: a retrospective matched cohort study. [PDF]

Sci Rep
Shen SP, Hou HA, Huang KC, Goh CH, Qiu H, Rothwell LA, Wu KW, Chandwani H, Liu Y, Tang CH.   +9 more
europepmc   +1 more source

Educational attainment, electroencephalographic rhythms, cortical structure, and cognitive performance over 2 years in older adults with subjective memory complaints and brain amyloidosis

Alzheimer's &Dementia, Volume 21, Issue 7, July 2025.
Abstract INTRODUCTION We investigated whether older adults with subjective memory complaints (SMC) and amyloid‐β accumulation may show clinical progression over 2 years, as measured by resting‐state electroencephalographic (rsEEG), structural magnetic resonance imaging (sMRI), and cognitive variables, depending on educational attainment.
Susanna Lopez, Harald Hampel, Claudio Del Percio, Giuseppe Noce, Roberta Lizio, Stefan J. Teipel, Martin Dyrba, Gabriel González‐Escamilla, Hovagim Bakardjian, Patrizia Andrea Chiesa, Enrica Cavedo, Andrea Vergallo, Pablo Lemercier, Giuseppe Spinelli, Michel J. Grothe, Marie‐Claude Potier, Fabrizio Stocchi, Chiara Coletti, Raffaele Ferri, Matteo Pardini, Marie‐Odile Habert, Simone Marziali, Bruno Dubois, Claudio Babiloni, and INSIGHT‐preAD study group   +24 more
wiley   +1 more source

Renal Transplant Outcomes in Plasma Cell Dyscrasias and AL Amyloidosis after Treatment with Daratumumab. [PDF]

J Clin Med
Mohidin B, Needleman A, Fernando R, Lowe DM, Wechalekar A, Sheaff M, Salama A, Jones G.   +7 more
europepmc   +1 more source

Moving Beyond G‐CSF Mobilization—Learning From a 15‐Year Experience of Different Stem Cell Mobilization Regimens in Multiple Myeloma

Cancer Medicine, Volume 14, Issue 14, July 2025.
We analysed our 15‐year data of various stem‐cell mobilization regimens in myeloma. Cyclophosphamide‐based chemo‐mobilization regimens with or without Bortezomib have the advantage of higher total stem‐cell yield, while they are equivalent to G‐CSF + Plerixafor for harvest in a single apheresis. Bortezomib + GCSF is an inferior regimen for mobilization.
Sumeet Mirgh, Bhausaheb Bagal, Sachin Punatar, Anant Gokarn, Nishant Jindal, Akanksha Chichra, Lingaraj Nayak, Sumathi Hiregoudar, Minal Poojary, Suryatapa Saha, Sarika Parab, Shashank Ojha, Prashant Tembhare, Nikhil Patkar, Sweta Rajpal, Gaurav Chatterjee, Libin Mathew, Papagudi Subramanian, Navin Khattry   +18 more
wiley   +1 more source

Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis. [PDF]

Nat Commun
Karimi-Farsijani S, Pfeiffer PB, Banerjee S, Baur J, Kuhn L, Kupfer N, Hegenbart U, Schönland SO, Wiese S, Haupt C, Schmidt M, Fändrich M.   +11 more
europepmc   +1 more source